By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.

Contact Information

Website: www.nucana.com
Email: info@nucana.com
Main Phone: +44 1313571111
Address: 3 Lochside Way
City / Town: Edinburgh
Country: GB
Postal Code: EH12 9DT

Issuer Information

Exchange: NGS
CEO: Hugh Griffith
Employees: 29

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A